Showing results (11-20 of 280) with videos related to

Sort By:
Pageof 28
Blood|March 2, 2013
Demethylation demystificationLauren Suarez, Steven D Gore
Hematology. American Society of Hematology. Education Program|December 10, 2021
Oral hypomethylating agents: beyond convenience in MDSElizabeth A Griffiths
Current Opinion in Hematology|November 20, 2023
Transfusion avoidance in myelodysplastic neoplasmsElizabeth A Griffiths
Epigenomics|November 30, 2011
Epigenetic targets in human neoplasmsTamer E Fandy, Steven D Gore
Seminars in Hematology|July 15, 2005
Future directions for the use of hypomethylating agentsGuillermo Garcia-Manero, Steven D Gore
Expert Review of Hematology|October 8, 2013
Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?Amer M Zeidan, Steven D Gore
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2014
New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approachAmer M Zeidan, Steven D Gore
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for the treatment of myelodysplastic syndromePhilip J Nivatpumin, Steven D Gore
Leukemia & Lymphoma|February 2, 2022
Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesisRory M Shallis, Steven D Gore
Epigenetics|July 31, 2010
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemiaElizabeth A Griffiths, Steven D Gore, Craig M Hooker, et al.
Pageof 28